Clinical Benefits of Above-Standard Dose of Octreotide LAR in Patients With Neuroendocrine Tumors for Control of Carcinoid Syndrome Symptoms: A Multicenter Retrospective Chart Review Study

Published 2014 View Full Article

Authors

Keywords

Journal

ONCOLOGIST

Volume 19, Issue 9, Pages 930-936

Publisher

Alphamed Press

Online

2014-08-06

DOI

10.1634/theoncologist.2014-0120

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

ONCOLOGIST

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Add your recorded webinar